The tumor (dark region, left) in this mouse brain was eradicated (arrowhead, right) with a novel drug cocktail, according to a Journal of Experimental Medicine study. Credit: vom Berg et al., 2013
A novel immune-boosting drug combination eradicates brain cancer in mice, according to a study in The Journal of Experimental Medicine.
Glioblastoma is the most aggressive form of brain cancer, and current treatments only modestly prolong patient survival. Immune cells called T cells have the capacity to attack and kill tumor cells, but tumors can counteract this attack by creating an environment that dampens T cell activity. T cells have ways of limiting their own activation (and thus autoimmunity), one of which is to express inhibitory cell surface proteins upon activation. In other cancer models, strategies to block these inhibitory proteins have been shown to reinvigorate T cell activation and thus promote tumor regression.
Burkhard Becher and colleagues at the University of Zurich now show that a two-pronged approach is most effective against glioblastoma. They simultaneously injected mice with a T cell–boosting protein called interleukin-12 and a drug that blocks the inhibitory receptor CTLA-4. The cocktail eradicated the animals' brain tumors.
Whether these findings will pave the way for a new therapeutic approach to treat glioblastoma in humans awaits clinical trials.
Explore further: New immuno-therapy for malignant brain tumors
More information: vom Berg, J., et al. 2013. J. Exp. Med. DOI: 10.1084/jem.20130678
Medical Xpress on facebook
Related Stories
Where and how are fear-related behaviors and anxiety disorders controlled?
Nov 21, 2013
Using an approach combining in vivo recordings and optogenetic manipulations in mice, the researchers succeeded in showing that the inhibition of parvalbumin-expressing prefrontal interneurons triggers a chain reaction resulting ...
Study sheds light on nerve regeneration following spinal cord injury
Nov 21, 2013
Fish, unlike humans, can regenerate nerve connections and recover normal mobility following an injury to their spinal cord. Now, University of Missouri researchers have discovered how the sea lamprey, an ...
Researchers find HIV protein may impact neurocognitive impairment in infected patients
Nov 15, 2013
A protein shed by HIV-infected brain cells alters synaptic connections between networks of nerve cells, according to new research out of the University of Minnesota. The findings could explain why nearly half of all patients ...
Predicting cancer's next move
Nov 11, 2013
Research led by Broad senior associate member Levi Garraway and published this week in Nature offers a new approach to studying drug resistance in cancer. The approach helped them identify which biological pathwa ...
Unlocking a secret of stem cell stability
Nov 06, 2013
Proper embryonic development depends on a signaling pathway that helps to preserve stem cell "immaturity."
Hitting inflammation in the guts
Nov 06, 2013
Researchers in UCD Conway Institute and Systems Biology Ireland have identified a way that a new class of anti-inflammatory drugs may be used to treat inflammatory bowel disease (IBD).
Recommended for you
New immuno-therapy for malignant brain tumors
1 hour ago
Animal experiments show that it is relatively easy to treat cancer in the early stages. However, it is far more difficult to successfully treat advanced cancer. Treatment of brain tumors is particularly challenging because ...
Severe flu complications for cancer patients
2 hours ago
It is often noted that very young people and the elderly are most at-risk for experiencing flu-related complications, and one expert at the University of Alabama at Birmingham says people with weakened immune ...
Do aging cells become cancer?
2 hours ago
Cancers that occur in later life could be down to the way our cells age, according to a paper published in Nature Cell Biology.
Potential new treatments for acute myeloid leukemia
2 hours ago
Two separate studies yield key findings for the prevention, diagnosis, treatment and cure for acute myeloid leukemia (AML). AML is a group of heterogeneous diseases with considerable diversity in terms of genetic abnormalities. ...
A better pump for pediatric brain cancer
3 hours ago
Treating pediatric brain cancer can be a challenge, since the brain has ways to protect itself from drugs taken orally or intravenously. One solution to this frustrating problem: A miniature, implantable ...
Certain symptom clusters experienced after surgery for esophageal cancer predict poor prognosis
12 hours ago
A new study has found that several months after surgery for esophageal cancer, different symptoms cluster together in different types of patients. In addition, patients with certain symptom clusters have an increased risk ...
User comments
© Medical Xpress 2011-2013, Phys.org network
The tumor (dark region, left) in this mouse brain was eradicated (arrowhead, right) with a novel drug cocktail, according to a Journal of Experimental Medicine study. Credit: vom Berg et al., 2013
A novel immune-boosting drug combination eradicates brain cancer in mice, according to a study in The Journal of Experimental Medicine.
Glioblastoma is the most aggressive form of brain cancer, and current treatments only modestly prolong patient survival. Immune cells called T cells have the capacity to attack and kill tumor cells, but tumors can counteract this attack by creating an environment that dampens T cell activity. T cells have ways of limiting their own activation (and thus autoimmunity), one of which is to express inhibitory cell surface proteins upon activation. In other cancer models, strategies to block these inhibitory proteins have been shown to reinvigorate T cell activation and thus promote tumor regression.
Burkhard Becher and colleagues at the University of Zurich now show that a two-pronged approach is most effective against glioblastoma. They simultaneously injected mice with a T cell–boosting protein called interleukin-12 and a drug that blocks the inhibitory receptor CTLA-4. The cocktail eradicated the animals' brain tumors.
Whether these findings will pave the way for a new therapeutic approach to treat glioblastoma in humans awaits clinical trials.
Explore further: New immuno-therapy for malignant brain tumors
More information: vom Berg, J., et al. 2013. J. Exp. Med. DOI: 10.1084/jem.20130678
Medical Xpress on facebook
Related Stories
Where and how are fear-related behaviors and anxiety disorders controlled?
Nov 21, 2013
Using an approach combining in vivo recordings and optogenetic manipulations in mice, the researchers succeeded in showing that the inhibition of parvalbumin-expressing prefrontal interneurons triggers a chain reaction resulting ...
Study sheds light on nerve regeneration following spinal cord injury
Nov 21, 2013
Fish, unlike humans, can regenerate nerve connections and recover normal mobility following an injury to their spinal cord. Now, University of Missouri researchers have discovered how the sea lamprey, an ...
Researchers find HIV protein may impact neurocognitive impairment in infected patients
Nov 15, 2013
A protein shed by HIV-infected brain cells alters synaptic connections between networks of nerve cells, according to new research out of the University of Minnesota. The findings could explain why nearly half of all patients ...
Predicting cancer's next move
Nov 11, 2013
Research led by Broad senior associate member Levi Garraway and published this week in Nature offers a new approach to studying drug resistance in cancer. The approach helped them identify which biological pathwa ...
Unlocking a secret of stem cell stability
Nov 06, 2013
Proper embryonic development depends on a signaling pathway that helps to preserve stem cell "immaturity."
Hitting inflammation in the guts
Nov 06, 2013
Researchers in UCD Conway Institute and Systems Biology Ireland have identified a way that a new class of anti-inflammatory drugs may be used to treat inflammatory bowel disease (IBD).
Recommended for you
New immuno-therapy for malignant brain tumors
1 hour ago
Animal experiments show that it is relatively easy to treat cancer in the early stages. However, it is far more difficult to successfully treat advanced cancer. Treatment of brain tumors is particularly challenging because ...
Severe flu complications for cancer patients
2 hours ago
It is often noted that very young people and the elderly are most at-risk for experiencing flu-related complications, and one expert at the University of Alabama at Birmingham says people with weakened immune ...
Do aging cells become cancer?
2 hours ago
Cancers that occur in later life could be down to the way our cells age, according to a paper published in Nature Cell Biology.
Potential new treatments for acute myeloid leukemia
2 hours ago
Two separate studies yield key findings for the prevention, diagnosis, treatment and cure for acute myeloid leukemia (AML). AML is a group of heterogeneous diseases with considerable diversity in terms of genetic abnormalities. ...
A better pump for pediatric brain cancer
3 hours ago
Treating pediatric brain cancer can be a challenge, since the brain has ways to protect itself from drugs taken orally or intravenously. One solution to this frustrating problem: A miniature, implantable ...
Certain symptom clusters experienced after surgery for esophageal cancer predict poor prognosis
12 hours ago
A new study has found that several months after surgery for esophageal cancer, different symptoms cluster together in different types of patients. In addition, patients with certain symptom clusters have an increased risk ...
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment